Mackay Shields LLC’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,735	Closed	-$2.36M	–	1183
2021 Q1	$2.36M	Sell	20,735 -12,836	-38%	-$1.75M	0.02%	699
2020 Q4	$4.65M	Sell	33,571 -4,500	-12%	-$534K	0.03%	506
2020 Q3	$3.13M	Sell	38,071 -5,100	-12%	-$423K	0.02%	597
2020 Q2	$3.38M	Buy	43,171 +3,200	+8%	+$212K	0.03%	526
2020 Q1	$1.77M	Sell	39,971 -6,400	-14%	-$332K	0.02%	714
2019 Q4	$1.98M	Sell	46,371 -600	-1%	-$24.8K	0.01%	878
2019 Q3	$2.01M	Sell	46,971 -800	-2%	-$43.5K	0.01%	899
2019 Q2	$3.03M	Buy	47,771 +30,836	+182%	+$1.96M	0.02%	753
2019 Q1	$1.17M	Buy	16,935 +1,300	+8%	+$74.3K	0.01%	945
2018 Q4	$679K	Sell	15,635 -1,663	-10%	-$90.9K	0.01%	1061
2018 Q3	$1.32M	Buy	17,298 +1,900	+12%	+$155K	0.01%	815
2018 Q2	$1.18M	Sell	15,398 -300	-2%	-$19.4K	0.01%	907
2018 Q1	$800K	Buy	+15,698	New	+$791K	0.01%	1030